Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3)Yuankai Shi, Luyao Sun, Yan Wang et al.|癌症：英文版|2022Cited by 60
Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathwayBo Peng, Guo‐Min Li|Journal of Biological Chemistry|2019Cited by 31